Mehdi Golchin

Dr. Mehdi Golchin

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MKMohammad Khalili
Mohammad Khalili
NSNaser Shahabi-Nejad
Naser Shahabi-Nejad
MGMehdi Golchin
Mehdi Golchin
There is little information on human Q fever in Iran and other Middle East countries. The aim of this study was to determine apparent Q fever seropositivity among febrile patients with suspected brucellosis in southeast Iran. Coxiella burnetii phases I and II specific IgG antibodies were measured by a commercial enzyme-linked immunosorbent assay (ELISA) in sera from 75 febrile patients. Phase I antibodies were detected in 18 subjects (24%) and phase II antibodies in 27 subjects (36%). This is the first report of human Q fever seropositivity in Iran after 3 decades and demonstrated a high prevalence of C. burnetii exposure in the sampled febrile patients.

1 June 2016 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
MAMojtaba Alimolaei
Mojtaba Alimolaei
MGMehdi Golchin
Mehdi Golchin
HDHamid Daneshvar
Hamid Daneshvar

19 September 2025 in Virulence
Verified
Journal Article
Open access
MAMohadese Amiri
Mohadese Amiri
MGMehdi Golchin
Mehdi Golchin
MMMajid Jamshidian Mojaver
Majid Jamshidian Mojaver
HFHamidreza Farzin
Hamidreza Farzin
AHAbbas Hajizade
Abbas Hajizade
Enterobactin, a high-affinity siderophore produced by Escherichia coli and other enteric pathogens, plays a critical role in bacterial iron acquisition and virulence. By sequestering iron from host environments, enterobactin enables bacterial survival and proliferation, even under iron-limited conditions typical of host tissues. This review explores the biosynthesis and regulation of enterobactin, highlighting its contribution to bacterial pathogenesis and immune evasion. We discuss the potential of targeting enterobactin for the development of live-attenuated vaccines, emphasizing the attenuation of virulence through genetic knockout of enterobactin biosynthesis genes (e.g. entB). Additionally, we examine enterobactin as a promising target for novel antimicrobial strategies, including small-molecule inhibitors and siderophore-based "Trojan horse" antibiotics. Beyond medical applications, we also explore the biotechnological and environmental potential of enterobactin, such as its use in bioremediation and drug delivery systems. Finally, we identify key gaps in current research and propose future directions for harnessing enterobactin to combat bacterial infections and address global health challenges. This review underscores the multifaceted role of enterobactin in bacterial biology and its potential as a cornerstone for innovative therapeutic and biotechnological applications.


10 May 2019 in Comparative Immunology, Microbiology and Infectious Diseases
Verified
Journal Article
Closed access
ZLZinat Lotfi
Zinat Lotfi
MGMehdi Golchin
Mehdi Golchin
AKAliakbar Khalili-Yazdi
Aliakbar Khalili-Yazdi
MKMohammad Khalili
Mohammad Khalili

3 February 2016 in International Journal of Enteric Pathogens
Verified
Journal Article
Open access
PDF file
MAMojtaba Alimolaei
Mojtaba Alimolaei
MGMehdi Golchin
Mehdi Golchin
An Efficient DNA Extraction Method for Lactobacillus casei , a Difficult-to-Lyse Bacterium - International Journal of Enteric Pathogens - - Alborz University of Medical Sciencs, Alborz, IR Iran